OCT 07, 2020 1:22 PM PDT

Delivering Cancer Drugs to Osteosarcoma with Nanoparticles

WRITTEN BY: Jasper Cantrell

Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The secret to a truly effective chemo or immunotherapy is not its effectiveness in killing a cancer cell, but its ability to target cancer over everything else.

The problem with cancer is that it looks so similar to the rest of the body’s cells. Decades of research has gone into identifying cancer biomarkers that allow scientists to identify cancer cells. Now we have several markers of cancer as a whole and specific markers for particular cancers.

Now scientists just needed to find a way to target those cancer cells. The most common mechanism used is inhibition of a critical protein to stop cell growth in some way. Immunotherapies will often use antibodies targeted to cancer markers on cancer cells, promoting the immune system to get rid of them that way. Another, more complex, method centered around a delivery method using a “targeting” molecule attached to a “carrier” molecule

In a new study out of Jilan University in China, a team decided to use this targeted carrier system against osteosarcomas. The bisphosphonate zoledronic acid (a drug that can treat various bone diseases) would be used as the “targeting” molecule, and PLGA nanoparticles (a molecule that forms a sort of shell to encase other molecules in) as the “carrier”. They chose several anti-cancer drugs to be loaded onto the resulting nanoparticle and tested their ability to target the complex to bones and treat osteosarcoma.

The team used bone powder to confirm that zoledronic acid could successfully target the complex to bone. The nanoparticles were also successful at encapsulating the anti-cancer drugs and could release them over an extended period (80-120 hours).

The team then compared the nanoparticles to the free anti-cancer drugs alone. The nanoparticles were less toxic and were taken into osteosarcoma cells better than the free anti-cancer drugs. In a mouse model, the nanoparticles performed just as well as free drugs against an osteosarcoma tumor, with one of the nanoparticle candidates coming out with a slight edge.

This study found that bone-targeted nanoparticles loaded with anti-cancer drugs performed better than free drugs in the lab, and just as well in a mouse model. Although the nanoparticles didn’t outperform the free drugs in the mouse model, the nanoparticles still represent a useful tool to target drugs to cancer.

The study concluded, “Our study presents the synthesis of nanoparticle drug delivery systems which resulted in a more encouraging pharmacokinetic profile with increased circulation time that could possibly augment the drug uptake and accumulation via passive diffusion method.”

Sources: Nature Scientific Reports, TheInnovationAcademy

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JUN 09, 2021
Technology
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
JUN 09, 2021
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
In a recent study published in Nature Medicine, researchers at the Princess Margaret Cancer Centre offer evidence for th ...
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
AUG 17, 2021
Clinical & Molecular DX
Delays in Breast Cancer Diagnoses Among Black Women
AUG 17, 2021
Delays in Breast Cancer Diagnoses Among Black Women
Thanks to breakthrough diagnostic technologies, we can now catch the early warning signs of breast cancer much faster th ...
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
OCT 25, 2021
Cell & Molecular Biology
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
OCT 25, 2021
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
Labroots virtual events are a great place to share research and learn about others work. These events feature participan ...
Loading Comments...